NDC Compounded Drug 69194-112-01 Edetate Disodium

Solution Ophthalmic

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching 112 Edetate Disodium 1.5% 1ml Vial
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 69194-112
NDC Package Code 69194-112-01
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 69194011201
Package Description 1 mL in 1 VIAL
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 112 Edetate Disodium 1.5% 1ml Vial
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Edetate Disodium 1.5% 1ml Vial
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Edetate Disodium
Dosage Form Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Route Name Ophthalmic - Administration to the external eye.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 69194
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Pine Pharmaceuticals Llc
Substance Name Edetate Disodium
Active Ingredients Information 15 mg/1 mL
Reporting Period 2024-1

NDC Crossover Products Matching Edetate Disodium

NDC crossover of 112 Edetate Disodium 1.5% 1ml Vial with NDC 69194-112 a human compounded drug with other similar products matching the same substance name (Edetate Disodium) and the same administration route (ophthalmic) or dosage form (solution).

Frequently Asked Questions

What is the NDC number assigned to Disodium Edetate Ophthalmic?

Disodium Edetate Ophthalmic was assigned by its manufacturer with NDC product code 69194-112. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Disodium Edetate Ophthalmic?

The NDC package code 69194-112-01 was assigned to a 1 mL in 1 VIAL of edetate disodium administered ophthalmic via solution.

Who manufactures this product?

Disodium Edetate Ophthalmic is manufactured by an outsourced facility and labeled by Pine Pharmaceuticals Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 1 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma with NDC product codes 26436-5557-1.